TipRanks
Addex Therapeutics (CH:ADXN)
:ADXN
Switzerland Market
ADXN
Addex Therapeutics
RESEARCH TOOLSreports
Want to see CH:ADXN full AI Analyst Report?

Addex Therapeutics (ADXN) Ratios

2 Followers

Addex Therapeutics Ratios

CH:ADXN's free cash flow for Q2 2026 was CHF-1.54. For the 2026 fiscal year, CH:ADXN's free cash flow was decreased by CHF and operating cash flow was CHF-64.84. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Dec 22
Liquidity Ratios
Current Ratio
 0.76 1.40 4.41 1.46 2.39
Quick Ratio
 0.76 1.40 4.41 1.46 2.39
Cash Ratio
 0.56 1.37 4.17 1.34 2.12
Solvency Ratio
 -4.34 -4.21 7.31 -2.93 -6.08
Operating Cash Flow Ratio
 -1.75 -1.81 -6.70 -2.76 -5.01
Short-Term Operating Cash Flow Coverage
 -43.85 0.00 -735.51 -29.17 -57.45
Net Current Asset Value
CHF -538.22KCHF 77.41KCHF 2.53MCHF 738.18KCHF 4.46M
Leverage Ratios
Debt-to-Assets Ratio
 0.02 <0.01 <0.01 0.07 0.05
Debt-to-Equity Ratio
 0.04 <0.01 <0.01 0.30 0.08
Debt-to-Capital Ratio
 0.04 <0.01 <0.01 0.23 0.07
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.00
Financial Leverage Ratio
 1.83 1.34 1.10 4.05 1.69
Debt Service Coverage Ratio
 -47.32 -175.94 -428.05 -34.70 -61.78
Interest Coverage Ratio
 -138.34 -175.94 -776.78 -103.81 -419.66
Debt to Market Cap
 0.02 0.00 <0.01 0.08 0.06
Interest Debt Per Share
 <0.01 <0.01 <0.01 <0.01 <0.01
Net Debt to EBITDA
 0.20 0.57 0.71 0.34 0.32
Profitability Margins
Gross Profit Margin
41.19%95.02%-108.35%-329.72%-928.06%
EBIT Margin
-5508.56%-1627.17%-1196.41%-653.13%-1459.14%
EBITDA Margin
-5486.04%-1627.17%-1132.98%-635.85%-1436.42%
Operating Profit Margin
-4115.07%-1627.17%-671.94%-139.06%-1442.61%
Pretax Profit Margin
-10867.08%-3955.25%-1197.28%-155.00%-1462.57%
Net Profit Margin
-10874.58%-3889.60%1720.75%-654.47%-1462.57%
Continuous Operations Profit Margin
-10867.08%-3955.25%-1197.28%-155.00%-1462.57%
Net Income Per EBT
100.07%98.34%-143.72%422.22%100.00%
EBT Per EBIT
264.08%243.08%178.18%111.47%101.38%
Return on Assets (ROA)
-197.62%-105.82%66.12%-227.41%-251.20%
Return on Equity (ROE)
-172.76%-141.32%72.96%-921.57%-423.46%
Return on Capital Employed (ROCE)
-123.10%-54.55%-27.92%-128.27%-410.41%
Return on Invested Capital (ROIC)
-120.01%-54.47%-27.87%-97.67%-368.26%
Return on Tangible Assets
-197.62%-105.82%66.12%-227.41%-251.20%
Earnings Yield
-180.65%-108.30%125.73%-308.83%-457.68%
Efficiency Ratios
Receivables Turnover
 2.12 8.61 26.43 10.66 2.38
Payables Turnover
 0.05 0.01 3.37 7.04 11.46
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 0.83 5.05 9.60 4.57 3.57
Asset Turnover
 0.02 0.03 0.04 0.35 0.17
Working Capital Turnover Ratio
 -0.35 0.11 0.20 0.55 0.13
Cash Conversion Cycle
 -7.04K -25.93K -94.41 -17.61 121.67
Days of Sales Outstanding
 171.81 42.38 13.81 34.23 153.53
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 7.21K 25.97K 108.22 51.84 31.86
Operating Cycle
 171.81 42.38 13.81 34.23 153.53
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.01 -0.02 -0.05 -0.11 -0.36
Free Cash Flow Per Share
 -0.01 -0.02 -0.05 -0.11 -0.36
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.00 1.00
Dividend Paid and CapEx Coverage Ratio
 -477.75K 0.00 -4.22K -1.17K -28.29K
Capital Expenditure Coverage Ratio
 -477.75K 0.00 -4.22K -1.17K -28.29K
Operating Cash Flow Coverage Ratio
 -30.82 -62.66 -127.96 -23.21 -44.05
Operating Cash Flow to Sales Ratio
 -37.80 -12.56 -13.11 -4.96 -11.56
Free Cash Flow Yield
-72.14%-34.98%-95.77%-234.02%-361.62%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -0.46 -0.92 0.80 -0.32 -0.22
Price-to-Sales (P/S) Ratio
 52.40 35.91 13.69 2.12 3.20
Price-to-Book (P/B) Ratio
 2.00 1.30 0.58 2.98 0.93
Price-to-Free Cash Flow (P/FCF) Ratio
 -1.39 -2.86 -1.04 -0.43 -0.28
Price-to-Operating Cash Flow Ratio
 -1.59 -2.86 -1.04 -0.43 -0.28
Price-to-Earnings Growth (PEG) Ratio
 -0.02 <0.01 >-0.01 <0.01 -0.10
Price-to-Fair Value
 2.00 1.30 0.58 2.98 0.93
Enterprise Value Multiple
 -0.76 -1.64 -0.50 0.01 0.10
Enterprise Value
 2.62M 4.61M 2.31M -102.99K -2.04M
EV to EBITDA
 -0.76 -1.64 -0.50 0.01 0.10
EV to Sales
 41.49 26.64 5.64 -0.06 -1.43
EV to Free Cash Flow
 -1.10 -2.12 -0.43 0.01 0.12
EV to Operating Cash Flow
 -1.10 -2.12 -0.43 0.01 0.12
Tangible Book Value Per Share
 0.01 0.04 0.10 0.02 0.11
Shareholders’ Equity Per Share
 0.01 0.04 0.10 0.02 0.11
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 -0.01
Revenue Per Share
 <0.01 <0.01 <0.01 0.02 0.03
Net Income Per Share
 -0.04 -0.06 0.07 -0.14 -0.46
Tax Burden
 1.00 0.98 -1.44 4.22 1.00
Interest Burden
 1.97 2.43 1.00 0.24 1.00
Research & Development to Revenue
 2.58 3.88 1.45 0.61 10.31
SG&A to Revenue
 32.19 10.91 5.63 4.47 5.13
Stock-Based Compensation to Revenue
 0.36 0.00 0.00 0.00 2.59
Income Quality
 0.35 0.32 1.09 0.76 0.79
Currency in CHF